Search MED
MEDIFAST INC
NYSE · CIK 910329
Last close11.73
Daily change+0.30 (2.62%)
10 Years gain+7.06%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
MED · STANDARD
SIC 2090 · Miscellaneous Food Preparations & Kindred Products · Fiscal year end 1231
Fundamental
32.0Momentum
30.9Acceleration
18.5Confidence
89.0Annual Revenue17
Quarterly Revenue60
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth0.0 / 25
Quality6.5 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics9.0 / 10
Forward Indicators0.0 / 5
Signals
Net debt reductionNet debt declined versus the comparison period.
Warnings
Gross margin compression · MEDIUMGross margin compressed by 3.3163 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 3.8272 percentage points.
ROIC declining · MEDIUMROIC declined by 12.935 percentage points.
Key Metrics
Revenue Growth TTM-42.02%OK
Revenue CAGR 3Y-37.74%OK
Gross Margin70.22%OK
Operating Margin-3.68%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-12.25%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y1.71%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $385.79M | $275.19M | -$14.21M | $6.86M | $1.25M | 71.33% | -3.68% | 0.32% | -28.28% | 10.98M |
| 2025 FY Dec 31, 2024 | $602.46M | $444.62M | $2.88M | $24.48M | $17.02M | 73.8% | 0.48% | 2.83% | 3.77% | 10.96M |
| 2025 FY Dec 31, 2023 | $1.07B | $775.85M | $126.40M | $147.66M | $141.17M | 72.37% | 11.79% | 13.17% | 164.26% | 10.92M |
| 2024 FY Dec 31, 2022 | $1.60B | $1.14B | $184.81M | $194.57M | $177.89M | 71.34% | 11.56% | 11.13% | 179.87% | 11.28M |
| 2023 FY Dec 31, 2021 | $1.53B | $1.13B | $216.24M | $94.55M | $60.34M | 73.89% | 14.17% | 3.95% | 433.59% | 11.81M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $347.39M | sum latest 4 fiscal quarters Revenue | OK | 0001628280-26-051928, 0001628280-25-048332 |
| Revenue Growth TTM | -42.02% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0001628280-26-051928, 0001628280-25-048332 |
| Revenue CAGR 3Y | -37.74% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-008656 |
| Revenue CAGR 5Y | -16.22% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0001628280-26-008656 |
| Gross Profit CAGR 3Y | -37.74% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0001628280-26-008656 |
| Operating Income Growth | -1,506.28% | OperatingIncome_current / OperatingIncome_prior_year - 1 | OK | 0001628280-26-051928, 0001628280-25-048332 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 70.22% | Gross Profit / Revenue | OK | 0001628280-26-051928, 0001628280-25-048332 |
| Operating Margin | -3.68% | Operating Income / Revenue | OK | 0001628280-26-051928, 0001628280-25-048332 |
| ROIC | -12.25% | NOPAT / Average Invested Capital | OK | 0001628280-26-051928, 0001628280-25-048332 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0001628280-26-051928 |
| Current Ratio | 4.86x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $31.20 | Revenue / Diluted Shares | OK | 0001628280-26-051928, 0001628280-25-048332 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |